---
title: "STRATA CRITICAL MED INC C/WTS 07/05/2026 (TO PUR COM) | 8-K: FY2025 Q4 Revenue: USD 66.79 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277617320.md"
datetime: "2026-03-03T12:06:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277617320.md)
  - [en](https://longbridge.com/en/news/277617320.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277617320.md)
generator: "portal-rs"
---

# STRATA CRITICAL MED INC C/WTS 07/05/2026 (TO PUR COM) | 8-K: FY2025 Q4 Revenue: USD 66.79 M

Revenue: As of FY2025 Q4, the actual value is USD 66.79 M.

EBIT: As of FY2025 Q4, the actual value is USD -7.043 M.

### Fourth Quarter 2025 Financial Highlights

#### Segment Revenue

-   Logistics Revenue rose 35.3% year-over-year to $49.2 million in Q4 2025, from $36.4 million in Q4 2024. Clinical Revenue totaled $17.6 million in Q4 2025, comprising $7.8 million from Transplant Clinical Revenue and $9.8 million from Other Clinical Revenue .

#### Operational Metrics

-   Total Gross Profit increased 90.0% to $14.4 million in Q4 2025, up from $7.6 million in Q4 2024, with the Total Gross Margin increasing by approximately 80 basis points year-over-year to 21.6% in Q4 2025 from 20.8% in Q4 2024 .
-   Logistics Gross Profit grew 39.5% to $10.6 million in Q4 2025, versus $7.6 million in Q4 2024, and Logistics Gross Margin increased by approximately 70 basis points to 21.5% in Q4 2025 from 20.8% in Q4 2024 .
-   Clinical Gross Profit was $3.833 million in Q4 2025, with a Clinical Gross Margin of 21.8% .
-   Selling, General and Administrative (SG&A) Expenses increased to $19.341 million in Q4 2025, from $13.167 million in Q4 2024 .
-   Amortization of Intangible Assets rose to $1.476 million in Q4 2025, from $0.322 million in Q4 2024 .
-   Total Operating Expenses increased to $20.817 million in Q4 2025, from $13.489 million in Q4 2024 .
-   Operating Loss from Continuing Operations was - $6.405 million in Q4 2025, compared to - $5.904 million in Q4 2024 .
-   Net Loss from Continuing Operations decreased by $2.0 million year-over-year to - $5.4 million in Q4 2025, from - $7.4 million in Q4 2024 .
-   Adjusted EBITDA increased by $5.9 million year-over-year to $7.0 million in Q4 2025, compared to $1.1 million in Q4 2024, representing 10.4% of revenue in Q4 2025, up from 3.0% in Q4 2024 .

#### Cash Flow

-   Operating Cash Flow was - $8.3 million in Q4 2025 .
-   Free Cash Flow from Continuing Operations, before aircraft and engine acquisitions, was - $8.7 million in Q4 2025 .
-   Capital Expenditures totaled $2.0 million in Q4 2025, primarily for aircraft maintenance and ground logistics vehicles .

#### Unique Metrics

-   Cash and Short-Term Investments ended FY 2025 with $61.2 million .

### Full Year 2025 Financial Highlights

#### Segment Revenue

-   Logistics Revenue was $176.793 million for the full year 2025, an increase of 20.4% year-over-year from $146.817 million in 2024 .
-   Clinical Revenue totaled $20.348 million for the full year 2025 .

#### Operational Metrics

-   Net Loss from Continuing Operations was $20.1 million for the full year 2025 .
-   Adjusted EBITDA was $14.1 million for the full year 2025, exceeding the high end of guidance .
-   Adjusted EBITDA as a percentage of revenue was 7.1% for the full year 2025, up from 2.6% in 2024 .

### Financial Outlook for Full Year 2026

-   The company is raising its full year 2026 guidance, expecting Adjusted EBITDA between $29 million and $33 million, an increase from the previously projected $28-32 million . It also forecasts Free Cash Flow, before aircraft and engine acquisitions, to be between $15 million and $22 million .

### Related Stocks

- [SRTAW.US](https://longbridge.com/en/quote/SRTAW.US.md)

## Related News & Research

- [Here's How Much $100 Invested In Phillips 66 5 Years Ago Would Be Worth Today](https://longbridge.com/en/news/296635244.md)
- [Phillips 66 (PSX) Is Up 7.4% After Wartime-Driven Margin Surge and New Midstream Contracts - What's Changed](https://longbridge.com/en/news/296430558.md)
- [Phillips 66 ups committed receivables financing facility to $2 billion, extends maturity to August 2027](https://longbridge.com/en/news/296653000.md)
- [Copenhagen Capital 1H FY26 profit before tax more than doubled to DKK 42.1 million](https://longbridge.com/en/news/296217796.md)
- [M Split declares monthly dividend of $0.03125 for Class I, Class II preferred shares](https://longbridge.com/en/news/296359911.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**